Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

Name: Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy
Published: 2014
License: Public Domain

AstraZeneca · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

asthma

asthma, asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

Related documents